Early Intervention in Ulcerative Colitis: Ready for Prime Time?

被引:30
作者
Solitano, Virginia [1 ]
D'Amico, Ferdinando [1 ,2 ,3 ]
Zacharopoulou, Eirini [4 ]
Peyrin-Biroulet, Laurent [2 ,3 ]
Danese, Silvio [1 ,4 ]
机构
[1] Humanitas Univ, Dept Biomed Sci, I-20090 Milan, Italy
[2] Univ Lorraine, Univ Hosp Nancy, Dept Gastroenterol, F-54500 Vandoeuvre Les Nancy, France
[3] Univ Lorraine, Univ Hosp Nancy, Inserm NGERE U1256, F-54500 Vandoeuvre Les Nancy, France
[4] IRCCS, Humanitas Clin & Res Ctr, Dept Gastroenterol, IBD Ctr, I-20089 Milan, Italy
关键词
ulcerative colitis; early intervention; window of opportunity; top-down strategy; treat-to-target; INFLAMMATORY-BOWEL-DISEASE; EARLY RHEUMATOID-ARTHRITIS; ANTI-TNF THERAPY; CROHNS-DISEASE; RISK-FACTOR; COLORECTAL NEOPLASIA; NATURAL-HISTORY; DEEP REMISSION; TIGHT CONTROL; MANAGEMENT;
D O I
10.3390/jcm9082646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Growing evidence shows that ulcerative colitis (UC) is a progressive disease similar to Crohn's disease (CD). The UC-related burden is often underestimated by physicians and a standard step-up therapeutic approach is preferred. However, in many patients with UC the disease activity is not adequately controlled by current management, leading to poor long-term prognosis. Data from both randomized controlled trials and real-world studies support early intervention in CD in order to prevent disease progression and irreversible bowel damage. Similarly, an early disease intervention during the so-called "window of opportunity" could lead to better outcomes in UC. Here, we summarize the literature evidence on early intervention in patients with UC, highlighting strengths and limitations of this approach.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 63 条
  • [51] Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab - Results from the ASPIRE trial
    Smolen, JS
    van der Heijde, DMFM
    St Clair, EW
    Emery, P
    Bathon, JM
    Keystone, E
    Maini, RN
    Kalden, JR
    Schiff, M
    Baker, D
    Han, CL
    Han, J
    Bala, M
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (03): : 702 - 710
  • [52] Distinct inflammatory mechanisms mediate early versus late colitis in mice
    Spencer, DM
    Veldman, GM
    Banerjee, S
    Willis, J
    Levine, AD
    [J]. GASTROENTEROLOGY, 2002, 122 (01) : 94 - 105
  • [53] Torres J, 2016, J CROHNS COLITIS, V10, P1385, DOI 10.1093/ecco-jcc/jjw116
  • [54] Ulcerative colitis as a progressive disease: The forgotten evidence
    Torres, Joana
    Billioud, Vincent
    Sachar, David B.
    Peyrin-Biroulet, Laurent
    Colombel, Jean-Frederic
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (07) : 1356 - 1363
  • [55] Ulcerative colitis
    Ungaro, Ryan
    Mehandru, Saurabh
    Allen, Patrick B.
    Peyrin-Biroulet, Laurent
    Colombel, Jean-Frederic
    [J]. LANCET, 2017, 389 (10080) : 1756 - 1770
  • [56] Deep Remission at 1 Year Prevents Progression of Early Crohn's Disease
    Ungaro, Ryan C.
    Yzet, Clara
    Bossuyt, Peter
    Baert, Filip J.
    Vanasek, Thomas
    D'Haens, Geert R.
    Joustra, Vincent Wilhelmus
    Panaccione, Remo
    Novacek, Gottfried
    Reinisch, Walter
    Armuzzi, Alessandro
    Golovchenko, Oleksandr
    Prymak, Olga
    Goldis, Adrian
    Travis, Simon P.
    Hebuterne, Xavier
    Ferrante, Marc
    Rogler, Gerhard
    Fumery, Mathurin
    Danese, Silvio
    Rydzewska, Grazyna
    Pariente, Benjamin
    Hertervig, Erik
    Stanciu, Carol
    Serrero, Melanie
    Diculescu, Mircea
    Peyrin-Biroulet, Laurent
    Laharie, David
    Wright, John P.
    Gomollon, Fernando
    Gubonina, Irina
    Schreiber, Stefan
    Motoya, Satoshi
    Hellstrom, Per M.
    Halfvarson, Jonas
    Butler, James W.
    Petersson, Joel
    Petralia, Francesca
    Colombel, Jean-Frederic
    [J]. GASTROENTEROLOGY, 2020, 159 (01) : 139 - 147
  • [57] Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn's disease
    Ungaro, Ryan C.
    Aggarwal, Saurabh
    Topaloglu, Ozlem
    Lee, Wan-Ju
    Clark, Ryan
    Colombel, Jean-Frederic
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (09) : 831 - 842
  • [58] Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
    van der Kooij, S. M.
    Goekoop-Ruiterman, Y. P. M.
    de Vries-Bouwstra, J. K.
    Guler-Yuksel, M.
    Zwinderman, A. H.
    Kerstens, P. J. S. M.
    van der Lubbe, P. A. H. M.
    de Beus, W. M.
    Grillet, B. A. M.
    Ronday, H. K.
    Huizinga, T. W. J.
    Breedveld, F. C.
    Dijkmans, B. A. C.
    Allaart, C. F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (06) : 914 - 921
  • [59] Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients
    Veny, M.
    Esteller, M.
    Ricart, E.
    Pique, J. M.
    Panes, J.
    Salas, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (05) : 561 - 572
  • [60] Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics
    Williet, Nicolas
    Pillot, Claire
    Oussalah, Abderrahim
    Billioud, Vincent
    Chevaux, Jean-Baptiste
    Bresler, Laurent
    Bigard, Marc-Andre
    Gueant, Jean-Louis
    Peyrin-Biroulet, Laurent
    [J]. INFLAMMATORY BOWEL DISEASES, 2012, 18 (09) : 1641 - 1646